Biotech

All Articles

BioMarin stops preclinical gene therapy for heart disease

.After BioMarin carried out a springtime well-maintained of its own pipe in April, the firm has actu...

Eisai plants molecular adhesive SEED along with $1.5 B biobucks deal

.Significant Pharmas remain caught to the concept of molecular adhesive degraders. The most recent f...

Life scientific research credit score firm reveals along with $600M

.A brand new international lifestyle science credit scores firm, termed Symbiotic Funding, has actua...

BMS ditches TIGIT, walking away from $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing another large wager from the Caforio time, canceling an offer for Age...

Nuvation standstills wager prevention after considering period 1 record

.After checking out at phase 1 record, Nuvation Biography has actually made a decision to stop work ...

' Professional instinct' led FDA advisors to back Zevra's unusual disease med

.Zevra Rehabs' rare ailment medicine seems to be to be on the road to confirmation this fall after a...

Pfizer takes $230M struck after axing fell short DMD gene treatment

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene treatment breakdown has actually blown a $2...

AC Immune sees 'site' possible in Alzheimer's drug records

.After more than two decades of work on neurodegenerative health conditions, Swiss biotech AC Immune...

GSK goes down ph. 2 HPV vaccine over lack of best-in-class possible

.GSK has actually junked a period 2 individual papillomavirus (HPV) vaccine from its own pipe after ...

OS Treatments refiles $6M IPO to cash HER2 medicine, preclinical ADCs

.OS Therapies will certainly detail on the NYSE American sell exchange this morning using a $6.4 mil...